Healthcare -
Biotechnology - NASDAQ - US
$ 10.27
-2.38 %
$ 433 M
Market Cap
-3.4
P/E
URGN - CAPITAL EXPENDITURES
Capital Expenditures URGN - UroGen Pharma Ltd.
-194 K
LAST VALUE
49.21%
2 YEAR CAGR
19.10%
5 YEAR CAGR
-13.03%
10 YEAR CAGR